Full-Time

Senior Manager

Marketing Operations

Posted on 11/26/2024

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$158k - $198kAnnually

Mid, Senior

San Carlos, CA, USA

Hybrid position requiring in-office presence.

Category
General Marketing
PR & Communications
Growth & Marketing
Required Skills
Sales
Word/Pages/Docs
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides
Requirements
  • Bachelor’s degree required with 3-6 years of experience in executing Marketing brand initiatives and Marketing operations in pharmaceuticals or biopharma.
  • Experience in marketing execution at conferences, speaker bureaus, advisory boards is required.
  • Track record of being a collaborative team player, build positive partnerships, and adaptive to meet the needs of a growing business.
  • Strong critical thinker and problem solver with proactive mindset to build and manage processes that drive accountability and results.
  • Demonstrated ability to influence management and key business partners without authority.
  • Excellent organizational skills, ability to multi-task, and prioritize effectively to deliver results within reasonably established timelines.
  • Strong interpersonal skills including verbal and written communication and represent Revolution Medicines and embodies our corporate values.
  • Proficient in PowerPoint, Excel, Word, and variety of project management (i.e., Smartsheet) and communication platforms (i.e., Teams, portal development, newsletters).
  • Advanced degree preferred (MBA, etc.) with 4+ years of commercial launch experience.
  • Targeted Oncology product experience strongly preferred.
  • Proficiency in Marketing technology.
Responsibilities
  • Partners with congress planning team to execute large specific congresses and major conferences such as ASCO.
  • Coordinates KOL Touchpoints for Regional Insights & Engagement team and insure integrated approach with cross functional partners where appropriate.
  • Plans for congress receptions including collaborating with marketing and congress hosts, identifying location, partnering with vendors.
  • Works with agencies and the marketing team to facilitate future Promotional Review Committee (PRC) approvals of congress and reception materials, handling all logistics, ensure all materials are updated and available on-site, and coordinate distribution of print and promotional materials.
  • Works with Marketing team and local sales team to determine on-site logistics of regional congresses e.g. booth set-up, attendance, coverage, and PRC materials.
  • Develops relationships with society coordinators and vendors to identify sponsorship opportunities including product theaters, receptions, and local summits.
  • Submits and manage all marketing sponsorship applications and coordinate submissions with supporting organizations.
  • Works with Regional Insights & Engagement team, agency, and sales leadership to design efficient and effective speaker bureau operations.
  • Partners with Legal to monitor speaker-related compliance issues and develop plan to ensure all goals and milestones are met.
  • Supports the development and submission of annual Advisory Board Plan and individual Advisory Board Plans.
  • Leads logistics planning and execution for speaker bureau speaker training and support promotional speaker bureau execution.
  • Conducts onboarding and management of speaker bureau vendor.
  • Manages MLR review process, SOPs and meetings in partnership with Regulatory, Legal and Medical to ensure compliant and efficient review of promotional materials.
  • Executes and manages marketing contracts, SOWs, and MSAs through partnership with Legal and Procurement. Liaison and timely respond to vendor/agency inquiries and payment in partnership with finance and procurement.
  • Onboards and managing vendor media partners for print/production fulfilment, speaker bureaus, and advisory boards.
  • Manages external agency partners and projects from concept to completion on time and within budget, while measuring success and ensuring strategic alignment and executional excellence.
  • Plans and execute an enterprise internal excitement campaign aligned with launch planning.
  • Collaborates with the Marketing team to prioritize and further develop roles and responsibilities across various initiatives.
  • Facilitates project team meetings, drive accountability for decisions and actions, document meeting materials and decisions, and act as a primary contact for project team related information.
  • Establishes strong relationships with key internal functions including Sales, Market Access, Commercial Operations, Medical Affairs, Legal and Regulatory.
  • Works closely with Commercial Operations to increase operational excellence for the Marketing team across the Commercial Development function.

Revolution Medicines develops targeted treatments for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to inhibit the activity of RAS proteins that promote cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses specifically on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-3%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity

INACTIVE